Tito Fojo
Affiliations: | 1998- | NIH (NCI) |
Google:
"Tito Fojo"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Blagoev KB, Iordanov R, Zhou M, et al. (2021) Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer. Oncotarget. 12: 15-21 |
| Chen KG, Duran GE, Mogul MJ, et al. (2020) Genomic stability at the coding regions of the multidrug transporter gene : insights into the development of alternative drug resistance mechanisms in human leukemia cells. Cancer Drug Resistance (Alhambra, Calif.). 3: 959-979 |
| Laderian B, Zhou M, Fojo T. (2020) Distribution of cancer genes in human chromosomes. Seminars in Oncology |
| Laderian B, Mundi P, Fojo T, et al. (2020) Emerging Therapeutic Implications of STK11 Mutation: Case Series. The Oncologist |
| Leuva H, Sigel K, Zhou M, et al. (2019) A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide. Seminars in Oncology |
| Burotto M, Wilkerson J, Stein WD, et al. (2019) Adjuvant and neoadjuvant cancer therapies: A historical review and a rational approach to understand outcomes. Seminars in Oncology |
| Bauml JM, Vinnakota R, Anna Park YH, et al. (2018) Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck. Journal of the National Cancer Institute |
| Jawed I, Velarde M, Därr R, et al. (2018) Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy. Cellular and Molecular Neurobiology |
| Balasubramaniam S, Redon CE, Peer CJ, et al. (2018) Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung. Anti-Cancer Drugs |
| Moscow JA, Fojo T, Schilsky RL. (2017) The evidence framework for precision cancer medicine. Nature Reviews. Clinical Oncology |